Brooks Laboratories Limited (BROOKS) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Brooks Laboratories Limited (BROOKS) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.19 Million ≈ $34.55K USD) by net assets (Rs1.16 Billion ≈ $12.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Brooks Laboratories Limited for the company's overall valuation and market capitalisation.

Brooks Laboratories Limited - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Brooks Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Brooks Laboratories Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Brooks Laboratories Limited ranked by their cash flow conversion efficiency. Explore how high is Brooks Laboratories Limited's earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Botala Energy Ltd AU:BTE	-0.032x
Shreyans Industries Limited NSE:SHREYANIND	0.040x
Biofrontera Inc NASDAQ:BFRI	-0.278x
TG Metals Ltd AU:TG6	-0.028x
ReWalk Robotics Ltd NASDAQ:LFWD	-0.492x
Genius Group Ltd NYSE MKT:GNS	-0.103x
Aqua Corporation Public Company Limited BK:AQUA	0.005x
Sephaku Holdings Ltd JSE:SEP	0.054x

Annual Cash Flow Conversion Efficiency for Brooks Laboratories Limited (2007–2025)

The table below shows the annual cash flow conversion efficiency of Brooks Laboratories Limited from 2007 to 2025. View BROOKS live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs981.04 Million ≈ $10.61 Million	Rs17.62 Million ≈ $190.59K	0.018x	+112.17%
2024-03-31	Rs655.85 Million ≈ $7.09 Million	Rs-96.81 Million ≈ $-1.05 Million	-0.148x	+24.67%
2023-03-31	Rs739.53 Million ≈ $8.00 Million	Rs-144.91 Million ≈ $-1.57 Million	-0.196x	+29.70%
2022-03-31	Rs1.34 Billion ≈ $14.53 Million	Rs-374.41 Million ≈ $-4.05 Million	-0.279x	-594.81%
2021-03-31	Rs791.48 Million ≈ $8.56 Million	Rs44.59 Million ≈ $482.19K	0.056x	+159.05%
2020-03-31	Rs984.16 Million ≈ $10.64 Million	Rs-93.89 Million ≈ $-1.02 Million	-0.095x	-98.66%
2019-03-31	Rs1.05 Billion ≈ $11.37 Million	Rs-50.49 Million ≈ $-546.08K	-0.048x	+11.07%
2018-03-31	Rs1.14 Billion ≈ $12.38 Million	Rs-61.81 Million ≈ $-668.48K	-0.054x	-169.74%
2017-03-31	Rs1.24 Billion ≈ $13.41 Million	Rs96.01 Million ≈ $1.04 Million	0.077x	+16.39%
2016-03-31	Rs1.22 Billion ≈ $13.20 Million	Rs81.19 Million ≈ $878.02K	0.067x	+248.09%
2015-03-31	Rs1.11 Billion ≈ $12.05 Million	Rs21.29 Million ≈ $230.26K	0.019x	-81.66%
2014-03-31	Rs1.12 Billion ≈ $12.14 Million	Rs116.98 Million ≈ $1.27 Million	0.104x	+103.74%
2013-03-31	Rs1.05 Billion ≈ $11.40 Million	Rs53.90 Million ≈ $582.89K	0.051x	+361.70%
2012-03-31	Rs912.63 Million ≈ $9.87 Million	Rs-17.83 Million ≈ $-192.84K	-0.020x	-109.59%
2011-03-31	Rs194.27 Million ≈ $2.10 Million	Rs39.59 Million ≈ $428.16K	0.204x	-51.15%
2010-03-31	Rs136.42 Million ≈ $1.48 Million	Rs56.91 Million ≈ $615.45K	0.417x	+144.20%
2009-03-31	Rs85.37 Million ≈ $923.22K	Rs14.58 Million ≈ $157.71K	0.171x	-58.33%
2008-03-31	Rs49.11 Million ≈ $531.11K	Rs20.13 Million ≈ $217.73K	0.410x	+565.61%
2007-03-31	Rs17.58 Million ≈ $190.16K	Rs1.08 Million ≈ $11.71K	0.062x	--

About Brooks Laboratories Limited

NSE:BROOKS India Drug Manufacturers - Specialty & Generic

Market Cap

$19.60 Million

Rs1.81 Billion INR

Market Cap Rank

#25294 Global

#1398 in India

Share Price

Rs61.53

Change (1 day)

+0.49%

52-Week Range

Rs37.11 - Rs147.08

All Time High

Rs194.97